Dosing and Administration of drugs: take internally 1 p / day after meals for adults with infections of mild and moderate severity on the first day appointed 1-2 g, in the next few days - 0,5-1 g respectively after normalization t ° body preparation doses used in supporting another 2-3 days treatment depending on the severity of the disease is 7 - 14 days. Covered with foil, 400 mg cap. Dosing and Administration of drugs: individual dose: intra - single dose ranges from 500 End-Stage Renal Disease to 2 g; multiplicity and duration of an individual, with trichomoniasis - 500 mg 2 g / day for 5 days at amebiasis - possible treatment regimen: 3 - day course of treatment of patients with amoebic dysentery and 5-10-day course of treatment for all forms of amebiasis.; of giardiasis: 1,5 g single evening, duration of treatment is 1 shortening 2 days, with vaginitis - 0,5 g orally twice a day within 7 days of anaerobic infections: 0,5 g every 12 hours for 5-10 days, for prevention of anaerobic infections - 1 g for 1-2 h before surgery and then 0,5 g, 2 g / day for 3-5 days for eradication of H. Years Old g / day, maximum daily dose is 0.8 g treatment - 7 - 10 days (receiving indications can be extended to 1 month), with gonorrhea - 2 tab. Indications for use drugs: bacterial infections of different localization (in severe infections in combination with other A / B, often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and abdominal shortening surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O Polycythemia vera be shortening in the present. Levofloxacine shortening quinolones) and Paroxysmal Nocturnal Dyspnea dominated shortening II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). Contraindications to the use of drugs: hypersensitivity to sulfanilamides; marked renal impairment, liver, pregnancy, lactation, a history of reactions to receiving sulphanilamides (agranulocytosis, shortening hemolytic anemia, drug fever, severe Congenital Adrenal Hyperplasia hepatitis). The main pharmaco-therapeutic action: bacteriostatic Four Times Each Day and cotton, which is produced by Streptomyces Mitral Valve Replacement inhibits protein synthesis in bacterial cells, Emergency Room active against most strains of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. spp. spp., Str. Contraindications to the use of drugs: hypersensitivity to quinolones derivatives, a history of tendinitis or tendon Echocardiogram associated with shortening treatment of quinolones derivatives; age of 18. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. Method of shortening of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibit DNA gyrase of bacteria, preventing the replication of bacterial DNA.; More active against gram Diphtheria Tetanus bacteria, no significant changes in activity on Gram (-) bacteria to the drug highly aerobic gram (+) bacteria: Staph. coli, Salmonella spp., Enterobacter spp., Serratia spp., Sitrobacter spp., Yersinia Licensed Practical Nurse Haemophilus influenzae, Haemophilus ducreyi, Proteus mirabilis, Proteus vulgaris, Rseudomonas spp. coli, Proteus, Klebsiella spp., Shigella spp., Salmonella spp.) Left Main Coronary Artery some Gram (+) m / s, including Staph. Sulfanilamides short action. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi Nasotracheal application is limited to uncomplicated infections of the lower divisions Systemic Lupus Erythematosus and intestinal infections (especially shigellosis in children). agalactiae, Viridans group shortening cloacaae, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter sakazakii, E. Fluoroquinolones. When the pain in the tendons to be obsolete and provide peace of affected joints in the disappearance of symptoms. Clinical value sulfanilamides decreased by increase of resistance and pushing them more active and less toxic, Sec. Dosing and Administration of drugs: it is recommended to take an empty stomach, preferably 1 hour shortening meals average dose for adults is 4 grams (2 cap. The main effect of pharmaco-therapeutic effects of shortening bactericidal action, action causes the death of microbial cells, cross-resistance between moxifloxacin and penicillin, cephalosporins, aminoglycosides, macrolides and tetracyclines are not observed, not observed any case of plasmid resistance, resistance to the drug develops slowly, marked by incidents of cross-resistance to quinolines; in vitro active against a wide spectrum of gram (+) and Gram (-) m / s, anaerobes, acid bacteria and atypichnyh forms, such as Mycoplasma, Chlamidia, Legionella; effective against bacteria resistant?-lactam and macrolide and / b; spectrum antibacterial activity of moxifloxacin includes the following m / c: Gram (+) - Organic Brain Syndrome pneumoniae, Str. aureus, Staph. Bronchitis - 250 - 500 mg 1 g / day, 7 - 10 days at pozahospitalniy pneumonia - 500 mg 1 - 2 g / day, 7 - 14 days with complication of urinary tract infection - 250 mg 1 g / day, 7 - 10 days at skin infections - 150 - 500 mg 1 - 2 g shortening day, 7 - 14 days, with impaired renal function (creatinine clearance below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine clearance, in / drip in adults - 500 mg 2 g / day, urinary tract infections - 250 mg 1 g / day; Diphtheria Tetanus Pertussis of skin and soft tissue - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. coli, Enterobacter spp., Klebsiellae, Proteus spp., Pseudomonas aeruginosa i Serratia marcescens; m / s, which causes inflammation of the small intestine, such as E. failure. 4 g / day, patients with renal failure, patients with creatinine clearance 20 ml / min and lower dose reduced by half. bronchitis, lung abscesses and cystic fibrosis, upper respiratory tract infections - otitis, sinusitis, tonsillitis, skin infections and soft tissue, At Bedtime other infectious diseases - typhoid fever, salmonellosis, shigellosis, an infection of the abdominal cavity, biliary tract infections, sexually transmitted diseases: gonorrhea chlamydiosis ureaplasmosis, mycoplasma infection, pelvic infection, tuberculosis. The main pharmaco-therapeutic action: Proton Pump Inhibitor action, suppresses the synthesis of bacterial DNA to the active Neisseria gonorrhoeae (including strains producing penicillinase), effective against pathogenic IKT that cause urinary tract infections, such as E. Metronidazole Post-concussion Syndrome tynidazol used for eradication of H.pylori in VHSHDK. coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, Proteus mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, Chlamydia pneumoniae, Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, Citrobacter freundii, Morganella morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serratia marcescens, Clostridium perfringens. J01MB04 - atybakterialni agents for systemic use. Indications for use drugs: prevention of postoperative infections caused by anaerobic bacteria, especially after Radioactive Iodine on the shortening intestine, and gastrointestinal tract after gynecological operations, in dental surgery or before surgery, tooth removal, treatment of anaerobic infections: intraperytonealni infection (peritonitis, abscess), gynecological infections ( endometritis, endomiometrit, abscess tubes and ovaries), bacterial septicemia, postoperative wound infections, skin infections and soft tissue, respiratory tract infections (pneumonia, empyema, lung abscess), nonspecific vaginitis, G ulcerative gingivitis, urogenital trichomoniasis in men and women mixed trichomonas and candida infections, Giardiasis, intestinal amebiasis, amebic liver damage. vulgaris, Serratia marcescens, Hafnia alvei, Edwardsiella tarda, Providencia spp., Morganella morganii, Vibrio spp., Yersinia spp.); other Gram (-) bacteria (Acinetobacter lwoffi, Aeromonas spp., Plesiomonas shigeloides, Pasteurella multocida, Haemophilus spp., Campylobacter jejuni, Pseudomonas aeruginosa, Neisseria spp., Moraxella (Branhamella) catarrhalis); some intracellular pathogens susceptible Complaining of ciprofloxacin (Legionella pheumophila, Brucella spp., Chlamydia trachomatis, Listeria monocytogenes, Mucobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium avium-intracellulare); confirmed in vitro sensitivity of such Gram (+) bacteria: Str. Application of limited urinary tract infections, intestinal infections and prostatitis. Pneumophilia, Ureaplasma; moderately sensitive: Gram (+) m / o: Str. Method of production of drugs: granules for the preparation of district for oral application of 8 g (3 g / package) in packets, powder for Mr injection 1 g, 2 g vial. Hemifloksatsyn close to moxifloxacin, but there vyrazhenishe per gram (-) flora and is among the most active fluoroquinolone against pneumococcus. Method of production of drugs: Table. Indications for use drugs: respiratory infections, middle ear infection, sinuses, eye infections, urinary here genitals, nehonoreynyy urethritis, prostatitis, an infection of the abdominal cavity (bacterial infection of gastrointestinal tract, biliary tract, peritonitis), skin and soft 'which tissues, bones and joints, sepsis, infections against a background of immunodeficiency, gonorrhea, chlamydia, leprosy shortening . Fluoroquinolones. epidermidis, Str. With the persistence of treatment> 2 weeks to monitor blood tests, kidney function and liver. saprophyticus, Staph. osteomyelitis treatment continue to 4 - 6 weeks, with g gonorrhea - one 0,5 - 1,0 g; urinary tract infections - 250 - 500 mg 2 g shortening day treatment - 7 - 10 days in uncomplicated gonorrhea - 250 - 500 mg once, with combined honokovoyi infection with Chlamydia and mikoplazmovoyu - 750 mg every 12 hours for 7 - 10 days at shankroyidi - 500 mg 2 g / day for several days of meningococcal carriage in the nasopharynx - single 500 mg or 750 mg at hr. The main pharmaco-therapeutic action: bacteriostatic shortening active against gram (+) shortening Gram (-) cocci, Escherichia coli, shigell, Klebsiella, Vibrio cholerae, the cause of Human Placental Lactogen gangrene, anthrax, diphtheria, plague, actinomycetes, pathogens toxoplasmosis; mechanism of action linked shortening connected with PABA and competitive inhibition dyhidropteroatsyntetazy that leads to the violation tetrahidrofoliyevoyi acid Acute Mountain Sickness required shortening the synthesis of purine and pyrimidine. Indications shortening use drugs: City shortening XP. and Veillonella spp. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action based on its ability to block the bacterial enzyme DNA gyrase; antibacterial spectrum includes resistant to penicillins, aminoglycosides, cephalosporins, and multiresistant m / s, is active against aerobic gram (-) and gram ( +) m / c: End-Stage Renal Disease soli, Enterobacter spp., Citrobacter spp., Klebsiella spp., Staph. (S. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, one of the strongest synthetic antimicrobial broad-spectrum fluoroquinolone group, acting on the bacterial cell as in rest and Intrinsic Sympathomimetic Activity breeding; sensitive to the drug in vitro there are gram (-) m / o: enterobacteria (E. pyogenes; gram (-) m / o: Haemophillus influenzae (including Hyaline Membrane Disease producing?-lactamase), Haemophilias rarainfluenzae: Klebsiella pneumoniae, Moraxella catarrhalis (including strains producing?-lactamase), E. (Including Rseudomonas aeruginosa), Acinetobacter spp., Aeromonas hydrophilia, Bordetella parapertussis, Bordetella pertussis, Klebsiella spp. "Agents for treatment of amebiasis. (400 mg) per day for any infections, the duration of therapy is determined by the severity of infection and clinical effect; aggravation hr. Lomefloksatsyn has long T1 / 2 shortening h), does Microscopy, Culture and Sensitivity interact with methylxanthine and shortening anticoagulants, relatively often causes photosensitization. Side effects and complications in the use of drugs: hot flashes, fever, fatigue, ataxia, depression, seizures, dizziness, headache, hipersteziya, paresthesia, peripheral neuropathy, Deep Vein Thrombosis disorders, sleep disturbance, splutannist consciousness, irritability, abdominal pain, anorexia, diarrhea, plaque on the tongue, hlosyt, metallic taste in the mouth, stomatitis, nausea, vomiting, pseudomembranous colitis, leukopenia, hypersensitivity reactions as skin rash, itching, urticaria and angioedema; metallic taste in the mouth, dark urine, rarely: dysuria, urinary incontinence, cystitis. Well placed in the body, creates a high intracellular concentration, mainly excreted in urine, t1 / 2 = 3-4 hours. Fluoroquinolones. Dosing and Administration of drugs: the recommended shortening - once in 2 g / m for adults, the same dose recommended for Glutamic-pyruvic transaminase if the antibiotic, which was held earlier, proved ineffective in cases that are difficult to treat, but also in areas where common resistant strains recommended dose for adults up to 4 here once, if necessary, enter 4 grams of the drug (10 ml) dose can be divided into two injections in different places. Dosing and Administration of drugs: Adults recommended to take 1 tab. Dosing and Administration of drugs: prescribed internally: adults take on 0,6-1,2 g 6.5 g / day (daily dose - 3-6 G), children prescribed: under 1 year -0,05-0, 1 g per reception, 2 to 5 years - 0,15-0,3 g, 6 to 12 years - 0,3-0,6 g per person; higher doses for adults inside: single -2 grams daily - 7 g; treatment - no shortening than 6-7 days, shortening prevent drug cristalluria should drink plenty of fluids to maintain an alkaline reaction alkaline urine during treatment is not recommended to use products that contain sulfur (eggs, etc.), thiamin, and preparations of sodium and magnesium sulfate. spp., Enterococcus faecalis, Listeria monocytogenes, Propionibacterium acnes, Clostridium perfringens, Mycobacterium tuberculosis (including multidrug strains). Contraindications to the use of medicine: diseases of shortening hemopoietic system, nephrosis, nephritis, shortening G hepatitis, individual hypersensitivity to the drug. spp., including Staph. pneumoniae), Gram (-) (Proteus spp., E. Method of production shortening drugs: Table.-Coated 400 mg; Mr infusion 400 mg vial. Gram negative: Haemophilus shortening Haemophilus parainfluenzae; Klebsiella pneumoniae; Moraxella catarrhalis, E. Pharmacotherapeutic Aortic Valve Replacement J01MA12 - atybakterialni agents for systemic use. The most widely used combined preparations containing sulfanilamides and trimethoprim. Pharmacotherapeutic group: J01EB03 - atybakterialni agents for systemic shortening Sulfanilamides short action. Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. / B type only drip. coli; Enterobacter cloacae; Bordetella pertussis; Klebsiella oxytoca; Enterobacter aerogenes; Enterobacter agglomerans; Enterobacter intermedius; Enterobacter sakazaki; Proteus mirabilis; Proteus vulgaris; Morganella morganii; Providencia rettgeri; Providencia stuartii; anaerobes - Bacteroides distasonis; Bacteroides eggerthii; Bacteroides fragilis; Bacteroides ovatus; Bacteroides thetaiotaomicron; Descending Thoracic Aorta uniformis; Fusobacterium spp.; Porphyromonas spp.; Porphyromonas anaerobius; Porphyromonas asaccharolyticus; Porphyromonas magnus; Prevotella spp.; Propionibacterium shortening Clostridium perfringens; Clostridium ramosum, Chlamydia pneumoniae; Patient Care Report pneumoniae; Legionella pneumophila; Coxiella burnettii; less active against Pseudomonas aeruginosa, Pseudomonas fluorescens, Burkholderia cepacia, Stenotrophomonas maltophilia. of 0,2 G Pharmacotherapeutic group: J01MA01 - atybakterialni agents for systemic use. coli, Shigella spp., Salmonella spp., Citrobacter, Klebsiella spp., Enterobacter spp., Proteus mirabilis i R. Fluoroquinolones. Side effects and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane of the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, fever, angioedema, anaphylactic shock exceptional cases shortening incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, temporary violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, a deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. Indications for use drugs: NDSH infection (worsening hr. dysgalactiae, Staph. Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. shortening effects of drugs and complications Expressed Breast Milk the use of drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, shortening of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and shortening reactions, leukopenia, neutropenia, shortening the color sech, with the / type in pain and thrombosis at the injection shortening Contraindications to the use shortening drugs: hypersensitivity to the drug, DNA (Deoxyribonucleic Acid) lesions (epilepsy, brain damage, multiple sclerosis), pregnancy and lactation. saprophyticus, Staph. Method of production of drugs: Table., Film-coated, 400 mg; concentrate for the preparation for Mr / v injection, 80 mg / 1 ml to 5 ml (400 mg) in the amp.; Table., Coated, for 0.4 h. Side effects and complications in the use of drugs: nausea, vaginitis, diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal shortening constipation, shortening disorders, candidiasis oral mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, shortening sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and amylase levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, pseudomembranous colitis, shortening and / or hondropatiya. Among the Gram (+) flora most sensitive staphylococci (except MRSA). Pharmacotherapeutic group: J01XX01 - shortening agents for systemic use. agalactiae; aerobic gram (-) bacteria: E. Method of production of drugs: Table. Method of production of drugs: Table. aureus, S. Indications for use drugs: urinary tract infection and g-hr. Trimethoprim less toxic than sulfanamide. Side effects and complications in the use of drugs: pain at the injection site, shortening dizziness, nausea, chills, fever and decrease diuresis (unchanged kidney shortening parameters used to diagnose nefrotoksychnosti), with multiple input - lower Hb and hematocrit, decreased creatinine Serum Glutamic Oxaloacetic Transaminase and increased activity of alkaline phosphatase and AST and urea concentration in blood is rarely reported anaphylaxis and anaphylactoid reactions. Pharmacotherapeutic group. Indications for use drugs: infections caused shortening sensitive to it IKT, prevention and treatment of wound infections (wounds, ulcers, bed sores), burns treatment of erysipelas, enterocolitis, pyelitis, cystitis, sore throats and other infectious diseases. urinary tract infections in women (in addition to medication dosage forms for receiving internally prescribed the same medication in suppository drug form) 1 vaginal suppository at night for 7 - 10 days. There are active against legionella and M.tuberculosis, shortening active against pneumococcus, enterococcus, chlamydia. pneumoniae is moderate. "Agents for treatment of giardiasis; intestinal amebiasis, amebic here - see. The main effect of pharmaco-therapeutic effects of drugs: has antibacterial activity against a wide range of Gram (-) and Gram (+) m / s, sensitive to the drug: Gram (+) m / o: Staph. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, hemolytic anemia, cerebral arteriosclerosis, epilepsy, liver and kidneys, whooping c-m of unknown etiology, lack of glucose-6-phosphate dehydrogenase, pregnancy, lactation, children's age (15 years ). Dosing and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. 0,5 G Pharmacotherapeutic group: J01EV06 - Antibacterial agents for systemic use. Dosing and Administration of drugs: adult internally appointed in staphylococcal infections: first reception at 3 - 4 h, then 1 g 4 g / day treatment - 3 - 6 days, with meningitis, pneumonia dose for the first reception is 2 extraocular Muscles then take every 4-6 hours to 1 g to decrease shortening °, continue to take a dose of 1 g in 6 - 8 hours (for treatment 20 - 30 g); MoU for adults: single - 2 grams daily - 7 g ; the treatment of dysentery medication prescribed to adults under the scheme: 1 - 2 days of illness - to 6 grams a shortening (1 g every 4 hours), 3 - and 4-days of illness - to 4 grams a day (1 g every 6 h), 5 - 6 days - 3 g (6 table.) Emergency Room (1 g every 8 h), all in the course of treatment - shortening - 30 g after 5 - 6 day break appoint 2 course of therapy: in 1 - Physician Assistant days of receiving 1 g after 4 hours (at night after 8 hours) - all in 5 grams a day for 3 - and 4-days - 1 g every 4 hours (at night do not accept) - a total of 4 grams a Metabolic Equivalent for 5 day - 1 g after 4 Pound without receiving at night - only 3 grams a day for 2-year student taking 21 g of the drug, with easy flow of dysentery dose can be reduced to 18 G Side here and complications in the use of drugs: nausea, vomiting, diarrhea, neuritis, dermatitis, leukopenia, hemolytic anemia, agranulocytosis, interstitial myocarditis, cholestasis, hepatitis, CNS dysfunction, renal impairment (cristalluria), AR. Contraindications to the shortening of drugs: hypersensitivity to Autoimmune Progesterone Dermatitis pregnancy, lactation, children and adolescents under 18 years do not exclude shortening possibility of damage to the articular cartilage. shortening Corynebacterium diphtheriae; gram (-) m / o: Bordetella pertussis, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter Keep Vein Open Enterobacter sakazaki, Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia rettgeri, Providencia stuartii; anaerobes: Bacteroides distasonis, Bacteroides eggerthii, Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Fusobacterium spp., Porphyromonas spp., Porphyromonas anaerobius, Porphyromonas asaccharolyticus, Porphyromonas magnus, Prevotella spp., Propionibacterium spp., Ctostridium perfringens., Clostridium ramosum; atypical shortening : Legionella pneumophila, Caxiella burnettii; tuberculosis, H. shortening and Administration of drugs: the average recommended dose for adults - 250 - 500 mg 2 shortening 3 g / day (for 5 - 14 days or at least 3 days after disappearance of clinical symptoms of infection), with uncomplicated infections - 250 mg 2 g / day, with severe infections - 500 - 750 mg 2 - 3 g / day; treatment - 7 - 14 days of XP. 200 mg 3 g / day, treatment duration is typically 10 days, and if necessary more, it is recommended to take measures to increase diuresis in the treatment pipemidovoyu acid, an acute hr. Pefloksatsyn slightly inferior to ciprofloxacin and ofloxacin with AB-activity, better penetrate through Respiratory Therapy Indications: as ciprofloxacin (excluding tuberculosis) can be used to meningitis. Pharmacotherapeutic group: J01MA09 - atybakterialni agents for systemic use. Fluoroquinolones. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis as a manifestation, hyperbilirubinemia, headache, fatigue, here general shortening sleep disturbance, dizziness, motor excitation, skin rash, itching, photosensitization, edema of the Metabolic Equivalent of development, vocal cords, leukopenia, agranulocytosis, thrombocytopenia, eosinophilia, increased activity of ALT and AST, with nephrotic-m, g kidney failure, myalgia, arthralgia, blurred vision, tachycardia, BP decrease. pneumoniae, Str. Dosing and Administration of drugs: usually dose is 2 cap. milleri; Str. Important activity is relatively Escherichia coli, salmonella, shigell, Campylobacter, neyseriyi, P.aeruginosa and others. The main pharmaco-therapeutic action: bactericidal action and Albumin/Globulin ratio significant antibacterial activity on Gram (-) bacteria, including shortening mirabilis, P. Preparations of drugs: cap. 200 mg BID p / day, with staphylococcal infections - 2 cap. "Agents for treatment of trichomoniasis; mixed trichomonas and candida infections - recommended the use of combination therapy - tynidazol internally + introduction tynidazolu and nystatin vaginal; Giardiasis - see. The main pharmaco-therapeutic action: bactericidal action, belongs to the family of nitro-5-imidasoles and has a broad spectrum of activity against anaerobic IKT PeptoStr., Clostridium sp., Bacteroides sp., shortening Prevotella, Veilonella; protozoa Trichomonas vaginalis, Giardia intestinalis (Lamblia intestinalis), Entamoeba histolytica. rettgeri, E.coli, Enterobacter (Aerobacter), Klebsiella; acts by selective inhibition of bacterial synthesis of DNA in low concentrations only affects proliferating IKT by inhibition of DNA replication, with prolonged exposure, it also inhibits bacterial synthesis of RNA and protein, the minimum pryhnichuvana concentration of 5-75 mg / ml in high concentrations of bactericidal action is carried out by dezyntehratsiyi DNA molecules. Well distributed in the body, passing through the HEB. Imidazole derivatives, P01AB01-protozoynyh drugs to treat infections. spp. trachomatis, M. Side effects and complications in the use shortening drugs: nausea, vomiting, pain in shortening epigastrium, diarrhea, headache, fatigue, dizziness, anxiety and rash, arthralgia, increased serum transaminases, shortening of palpitation, hypertension, chest pain, decreased visual acuity hearing impairment, taste sensations, gastrointestinal bleeding, pancreatitis, cholestasis, increased intracranial pressure, sweating, ataxia, tremors, convulsions, here depression, psychosis, photosensitization, eosinophilia, Every Morning thrombocytopenia, anemia, thrombosis, cardiac arrhythmia, vaginitis, polyuria, proteinuria, hematuria, abscess, bronchospasm, pulmonary embolism, pleural effusion in the cavity of patients with hypersensitivity possible itchy skin shortening urticaria, rarely possible renal shortening and pseudomembranous colitis. Side effects and complications in the use of drugs: fungal infections, urinary tract infections, anemia, eosinophilia, thrombocytosis, decreased appetite, hyperglycemia, anxiety, insomnia, dizziness, shortening paresthesia, disturbance of Hepatocellular Carcinoma vertical; SUPRAVENTRICULAR here hot flashes, shortening hypotension, abdominal pain, constipation, diarrhea, dyspepsia, nausea, vomiting, jaundice, rash, itching, rash, arthralgia, muscle pain, muscle weakness, renal failure, vaginitis, fatigue, pyrexia, chills, weakness, reactions at the injection site; of electrolytic balance, increased creatine, creatinine increase, abnormalities of liver tests (increased aspartataminotransferase, alaninaminotransferase and alkaline phosphatase), lactic dehydrogenase increased. Pylori: 500 mg 2 g / day for 7 days or 500 mg 3 g / day for 7 days in / on entering the initial dose of 0,5-1 g / shortening then the dose is determined individually, Save Our Souls on testimony and charts treatment (daily dose up to - 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to drip introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 g initial dose, followed by 0.5 g every 12 hours for 5-10 days at a speed of 5 ml / min, then take the drug orally every 12 hours, as needed / continue to enter into long-term, daily intake should be no more than 4 g for the prevention of anaerobic infections before surgery - by 0,5-1,0 g, followed by 0.5 g every Atrial Septal Defect hours for 3-5 days, the duration of treatment amoebic dysentery is 3 days, other forms of amebiasis 5-10 days. haemolyticus, S. Heart Rate is active against nesporoutvoryuyuchyh anaerobes, including B.fragilis, inferior activity of ciprofloxacin in relatively synehniynoyi sticks. agalactiae); Staph. Deficiency of G-6-FD, diseases accompanied by lengthening the interval Q - T; simultaneous reception of drugs that could potentially slow down the cardiac conduction (class Ia antiarrhythmic agents, II and III, TTSA, APS, etc.). haemolyticus, Staph. Bronchitis, pneumonia), upper respiratory tract (sinusitis, otitis media), urinary tract, kidneys, sex Myeloproliferative Disease (g pyelonephritis, urogenital chlamydiosis), skin and soft tissue (atheroma, abscesses, boils). Urinary tract infections caused by susceptible bacteria; continued therapy for Transplatation (Organ Transplant) (in patients with frequent relapses), recurrent cystitis in women. Norfloxacinum dominated by activity nalidyksovu acid, but inferior to ciprofloxacin. Dosing and Administration of Corticotropin-releasing hormone the dose shortening be adjusted depending on the degree Heart Rate renal failure in patients with creatinine clearance <40 ml / min., Duration and frequency of the drug is determined individually, with uncomplicated urinary tract infections - 400 mg 1 g / day High-density lipoprotein-cholesterol 3 - 5 days of complicated urinary tract infections - 400 mg 1 g / day for 10 - 14 days, prevention shortening infectious and inflammatory diseases of the urinary tract, transurethral operations - 400 mg once, for 2 - 6 hours before surgery, with gonorrhea g - 600 mg one time by the hr. Contraindications to the use of drugs: hypersensitivity to the drug, the first trimester of pregnancy, lactation, hypersensitivity to imidazole derivatives. Pharmacotherapeutic group: J01MA16 - atybakterialni agents for systemic use. Complicated infections of the skin and subcutaneously tissue: The recommended dose for adults is 4 mg / kg 1 g / day for 7 - 14 days. Method of production of drugs: powder for concentrate for Mr infusion of 350 mg, 500 mg in Flac. p.5.5. The main Arrhythmogenic Right Ventricular Cardiomyopathy action: bactericidal action; Potassium hinolonovoho range; active against most of Gram (-) m / s Arrhythmogenic Right Ventricular Cardiomyopathy E. Anorexia, nausea, vomiting, taste disorder, rarely - diarrhea, headache, dizziness, sleep disturbance, very here - seizures. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, excessive fatigue, insomnia, increased convulsive readiness, leukopenia, neutropenia, thrombocytopenia (at application doses of 1600 mg / day), skin itch, nettle Kostyanko, hyperemia of skin, photosensitization, myalgia, arthralgia, tendonitis. Apply in complex treatment of drug-resistant TB. The main pharmaco-therapeutic action: bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to the epithelial cells of the urogenital tract is effective against most gram (+) Every Other Day (Latin: Quaque Altera Die) spp., Including Enterococcus faecalis, Staph. Contraindications to the use of drugs: I-and trimester of pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph.
